Mechanisms of Disease: cancer stem cells—targeting the evil twin (original) (raw)

• Weissman IL (2000) Stem cells: units of development, units of regeneration, and units in evolution. Cell 100: 157–168
  Article CAS PubMed Google Scholar
• Murphy MJ et al. (2005) More than just proliferation: Myc function in stem cells. Trends Cell Biol 15: 128–137
  Article CAS PubMed Google Scholar
• Blanpain C et al. (2007) Epithelial stem cells: turning over new leaves. Cell 128: 445–458
  Article CAS PubMed PubMed Central Google Scholar
• Bruce WR and Van Der Gaag H (1963) A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199: 79–80
  Article CAS PubMed Google Scholar
• Reya T et al. (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105–111
  Article CAS PubMed Google Scholar
• Wang JC and Dick JE (2005) Cancer stem cells: lessons from leukemia. Trends Cell Biol 15: 494–501
  Article CAS PubMed Google Scholar
• Bonnet D and Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730–737
  Article CAS PubMed Google Scholar
• Al-Hajj M et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983–3988
  Article CAS PubMed PubMed Central Google Scholar
• Singh SK et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396–401
  Article CAS PubMed Google Scholar
• Hope KJ et al. (2004) Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5: 738–743
  Article CAS PubMed Google Scholar
• Wilson A et al. (2007) Dormant and self-renewing hematopoietic stem cells and their niches. Ann NY Acad Sci 1106: 64–75
  Article CAS PubMed Google Scholar
• Moore KA and Lemischka IR (2006) Stem cells and their niches. Science 311: 1880–1885
  Article CAS PubMed Google Scholar
• Wilson A and Trumpp A (2006) Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6: 93–106
  Article CAS PubMed Google Scholar
• Tan TT and Coussens LM (2007) Humoral immunity, inflammation and cancer. Curr Opin Immunol 19: 209–216
  Article CAS PubMed Google Scholar
• Li F et al. (2007) Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 17: 3–14
  Article CAS PubMed Google Scholar
• Kaplan RN et al. (2007) Niche-to-niche migration of bone-marrow-derived cells. Trends Mol Med 13: 72–81
  Article CAS PubMed Google Scholar
• Dar A et al. (2006) Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 34: 967–975
  Article CAS PubMed Google Scholar
• Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469–480
  Article CAS PubMed Google Scholar
• Beachy PA et al. (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324–331
  Article CAS PubMed Google Scholar
• Smith MA et al. (2001) Stem cell factor: biology and relevance to clinical practice. Acta Haematol 105: 143–150
  Article CAS PubMed Google Scholar
• Cully M et al. (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6: 184–192
  Article CAS PubMed Google Scholar
• Koch U and Radtke F (2007) Notch and cancer: a double-edged sword. Cell Mol Life Sci 64: 2746–2762
  Article CAS PubMed Google Scholar
• Sparmann A and van Lohuizen M (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6: 846–856
  Article CAS PubMed Google Scholar
• Jones PA and Baylin SB (2007) The epigenomics of cancer. Cell 128: 683–692
  Article CAS PubMed PubMed Central Google Scholar
• Huntly BJ et al. (2004) MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6: 587–596
  Article CAS PubMed Google Scholar
• Krivtsov AV et al. (2006) Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442: 818–822
  Article CAS PubMed Google Scholar
• Kim CF et al. (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823–835
  Article CAS PubMed Google Scholar
• Lapidot T et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645–648
  Article CAS PubMed Google Scholar
• O'Brien CA et al. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106–110
  Article CAS PubMed Google Scholar
• van Rhenen A et al. (2005) High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 11: 6520–6527
  Article CAS PubMed Google Scholar
• Klein CA and Holzel D (2006) Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics. Cell Cycle 5: 1788–1798
  Article CAS PubMed Google Scholar
• Pantel K and Alix-Panabieres C (2007) The clinical significance of circulating tumor cells. Nat Clin Pract Oncol 4: 62–63
  Article PubMed Google Scholar
• Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834–846
  Article CAS PubMed PubMed Central Google Scholar
• Shmelkov SV et al. (2005) AC133/CD133/Prominin-1. Int J Biochem Cell Biol 37: 715–719
  Article CAS PubMed Google Scholar
• Singh SK et al. (2004) Cancer stem cells in nervous system tumors. Oncogene 23: 7267–7273
  Article CAS PubMed Google Scholar
• Dirks PB (2006) Cancer: stem cells and brain tumours. Nature 444: 687–688
  Article CAS PubMed Google Scholar
• Ricci-Vitiani L et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111–115
  Article CAS PubMed Google Scholar
• Collins AT et al. (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946–10951
  Article CAS PubMed Google Scholar
• Huttner WB and Kosodo Y (2005) Symmetric versus asymmetric cell division during neurogenesis in the developing vertebrate central nervous system. Curr Opin Cell Biol 17: 648–657
  Article CAS PubMed Google Scholar
• Dubreuil V et al. (2007) Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1. J Cell Biol 176: 483–495
  Article CAS PubMed PubMed Central Google Scholar
• Prince ME et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973–978
  Article CAS PubMed PubMed Central Google Scholar
• Li C et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67: 1030–1037
  Article CAS PubMed Google Scholar
• Ponti D et al. (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506–5511
  Article CAS PubMed Google Scholar
• Sheridan C et al. (2006) CD44+/CD24– breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8: R59
  Article PubMed PubMed Central CAS Google Scholar
• Shackleton M et al. (2006) Generation of a functional mammary gland from a single stem cell. Nature 439: 84–88
  Article CAS PubMed Google Scholar
• Stingl J et al. (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439: 993–997
  Article CAS PubMed Google Scholar
• Abraham BK et al. (2005) Prevalence of CD44+/CD24–/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11: 1154–1159
  CAS PubMed Google Scholar
• Balic M et al. (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12: 5615–5621
  Article CAS PubMed Google Scholar
• Schabath H et al. (2006) CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 119: 314–325
  Article CAS PubMed Google Scholar
• Fang D et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328–9337
  Article CAS PubMed Google Scholar
• Patrawala L et al. (2007) Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 67: 6796–6805
  Article CAS PubMed Google Scholar
• Gibbs CP et al. (2005) Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7: 967–976
  Article CAS PubMed PubMed Central Google Scholar
• Liu G et al. (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5: 67
  Article PubMed PubMed Central CAS Google Scholar
• Druker BJ et al. (2001) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344: 1038–1042
  Article CAS PubMed Google Scholar
• Bhatia R et al. (2003) Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101: 4701–4707
  Article CAS PubMed Google Scholar
• Mauro MJ et al. (2004) Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remission. Leuk Res 28 (Suppl 1): S71–S73
  Article CAS PubMed Google Scholar
• Cortes J et al. (2004) Discontinuation of imatinib therapy after achieving a molecular response. Blood 104: 2204–2205
  Article CAS PubMed Google Scholar
• Diehn M and Clarke MF (2006) Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 98: 1755–1757
  Article PubMed Google Scholar
• Bao S et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756–760
  Article CAS PubMed Google Scholar
• Fleming WH et al. (1993) Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 122: 897–902
  Article CAS PubMed Google Scholar
• Tumbar T et al. (2004) Defining the epithelial stem cell niche in skin. Science 303: 359–363
  Article CAS PubMed Google Scholar
• Guan Y et al. (2003) Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 101: 3142–3149
  Article CAS PubMed Google Scholar
• Holyoake T et al. (1999) Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94: 2056–2064
  CAS PubMed Google Scholar
• Graham SM et al. (2002) Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99: 319–325
  Article CAS PubMed Google Scholar
• Copland M et al. (2006) Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood 107: 4532–4539
  Article CAS PubMed Google Scholar
• Jorgensen HG et al. (2007) Nilotinib exerts equipotent anti-proliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells. Blood 109: 4016–4019
  Article CAS PubMed Google Scholar
• Karrison TG et al. (1999) Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 91: 80–85
  Article CAS PubMed Google Scholar
• Jorgensen HG et al. (2006) Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate. Clin Cancer Res 12: 626–633
  Article CAS PubMed Google Scholar
• Brown JM and Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408–1416
  CAS PubMed Google Scholar
• Green SK et al. (1999) Adhesion-dependent multicellular drug resistance. Anticancer Drug Des 14: 153–168
  CAS PubMed Google Scholar
• Ito K et al. (2006) Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12: 446–451
  Article CAS PubMed Google Scholar
• Brown JM and Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437–447
  Article CAS PubMed Google Scholar
• von Pawel J et al. (2000) Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: a report of the international CATAPULT I study group. Cisplatin and tirapazamine in subjects with advanced previously untreated non-small-cell lung tumors. J Clin Oncol 18: 1351–1359
  Article CAS PubMed Google Scholar
• Rischin D et al. (2005) Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 23: 79–87
  Article CAS PubMed Google Scholar
• Giaccia A et al. (2003) HIF-1 as a target for drug development. Nat Rev Drug Discov 2: 803–811
  Article CAS PubMed Google Scholar
• Kiel MJ et al. (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109–1121
  Article CAS PubMed Google Scholar
• Calabrese C et al. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69–82
  Article CAS PubMed Google Scholar
• Tozer GM et al. (2005) Disrupting tumour blood vessels. Nat Rev Cancer 5: 423–435
  Article CAS PubMed Google Scholar
• Kincade PW (1999) Blasting away leukemia. Nat Med 5: 619–620
  Article CAS PubMed Google Scholar
• Jin L et al. (2006) Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12: 1167–1174
  Article CAS PubMed Google Scholar
• Biedler JL and Riehm H (1970) Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 30: 1174–1184
  CAS PubMed Google Scholar
• Gros P et al. (1986) Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc Natl Acad Sci USA 83: 337–341
  Article CAS PubMed PubMed Central Google Scholar
• Roninson IB et al. (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83: 4538–4542
  Article CAS PubMed PubMed Central Google Scholar
• Donnenberg VS and Donnenberg AD (2005) Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol 45: 872–877
  Article CAS PubMed Google Scholar
• Dean M et al. (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275–284
  Article CAS PubMed Google Scholar
• Goodell MA et al. (2005) Isolation and characterization of side population cells. Methods Mol Biol 290: 343–352
  PubMed Google Scholar
• Chiba T et al. (2006) Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44: 240–251
  Article CAS PubMed Google Scholar
• Hirschmann-Jax C et al. (2004) A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228–14233
  Article CAS PubMed PubMed Central Google Scholar
• Patrawala L et al. (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2– cancer cells are similarly tumorigenic. Cancer Res 65: 6207–6219
  Article CAS PubMed Google Scholar
• Szotek PP et al. (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 103: 11154–11159
  Article CAS PubMed PubMed Central Google Scholar
• Comerford KM et al. (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62: 3387–3394
  CAS PubMed Google Scholar
• Modok S et al. (2006) Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Curr Opin Pharmacol 6: 350–354
  Article CAS PubMed Google Scholar
• Pusztai L et al. (2005) Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma. Cancer 104: 682–691
  Article CAS PubMed Google Scholar
• Xu D et al. (2005) Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector. Mol Ther 11: 523–530
  Article PubMed CAS Google Scholar
• Piccirillo SG et al. (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761–765
  Article CAS PubMed Google Scholar
• Kelly PN et al. (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317: 337
  Article CAS PubMed Google Scholar
• Blair A and Sutherland HJ (2000) Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp Hematol 28: 660–671
  Article CAS PubMed Google Scholar
• Jordan CT et al. (2000) The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14: 1777–1784
  Article CAS PubMed Google Scholar
• Cox CV et al. (2004) Characterization of acute lymphoblastic leukemia progenitor cells. Blood 104: 2919–2925
  Article CAS PubMed Google Scholar
• Cox CV et al. (2007) Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood 109: 674–682
  Article CAS PubMed Google Scholar
• Hermann PC et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313–323
  Article CAS PubMed Google Scholar
• Yang ZF et al. (2008) Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13: 153–166
  Article CAS PubMed Google Scholar